Avantor® Announces Preliminary Third Quarter Unaudited Revenues
Avantor, Inc. (NYSE: AVTR) reported preliminary unaudited revenues for Q3 2020, with total revenues of $1.60 billion, reflecting a 6.7% increase and 5.4% organic growth. The results indicate strong performance, particularly in the biopharma and healthcare markets. The company will release full financial results on October 28, 2020. It is important to note that these figures are preliminary and unaudited, pending final review.
- Q3 2020 revenue of $1.60 billion, a 6.7% increase.
- Organic growth of 5.4%, indicating strong market performance.
- Notable growth in the biopharma and healthcare sectors.
- None.
RADNOR, Pa., Oct. 23, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, provided preliminary unaudited revenue estimates for the third quarter ended September 30, 2020, in conjunction with proposed debt refinancing transactions.
Preliminary Third Quarter 2020 Unaudited Revenues
- Revenue of
$1.60 billion , increasing6.7% ; organic growth of5.4% .
"Our third quarter revenue results reflect solid performance across our base business, including strong growth in the biopharma and healthcare end markets," said Michael Stubblefield, President and Chief Executive Officer at Avantor. "We look forward to sharing our full financial results on our third quarter earnings release call scheduled for October 28, 2020."
The estimated fiscal 2020 third quarter revenue results are preliminary and unaudited, reflect management's current views and may change as a result of management's review of results and other factors. Such preliminary results for the fiscal 2020 third quarter are subject to finalization, and should not be viewed as a substitute for full quarterly financial statements prepared in accordance with accounting principles generally accepted in the U.S. Our independent registered public accounting firm has not audited, nor have they completed their review and other procedures with respect to the preliminary results, nor have they expressed any opinion or any other form of assurance on the preliminary results.
About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, please visit www.avantorsciences.com.
Media Contact
Allison Hosak
Senior Vice President, Global Communications
Avantor
+1 908-329-7281
Allison.Hosak@Avantorsciences.com
Investor Relations Contact
Tommy J. Thomas, CPA
Vice President, Investor Relations
Avantor
+1 781-375-8051
Tommy.Thomas@Avantorsciences.com
View original content:http://www.prnewswire.com/news-releases/avantor-announces-preliminary-third-quarter-unaudited-revenues-301158498.html
SOURCE Avantor and Financial News
FAQ
What were Avantor's Q3 2020 revenue estimates?
How much did Avantor's revenues increase in Q3 2020?
What is Avantor's organic growth rate for Q3 2020?
When will Avantor announce its full financial results for Q3 2020?
Which sectors contributed to Avantor's revenue growth in Q3 2020?
